Additionally, anthocyanins have been shown to inhibit the aggregation of amyloid-beta peptides and tau protein phosphorylation, two hallmark features of AD pathology which are strongly associated with the gut–brain axis [30,38]. Here, MAPT is linked to Alzheimer disease.